bovnews1h
Why Fifth Third Bancorp (FITB) Stock is Currently 4.65% Above from Its 20-Day SMA?
On Friday, Fifth Third Bancorp (FITB) stock saw a decline, ending the day at $46.99 which represents a decrease of $-0.27 or -0.57% from the prior close of $47.26. The stock opened at $47.51 and ...
bovnews3h
Why Is Hess Corp (HES) Stock Surpassing 6.46% from Its 50-Day SMA?
On Friday, Hess Corp (HES) stock saw a modest uptick, ending the day at $145.64 which represents a slight increase of $0.58 or 0.40% from the prior close of $145.06. The stock opened at $144.67 and ...
Fintel on MSN7h
Wolfe Research Initiates Coverage of BioMarin Pharmaceutical (BMRN) with Outperform Recommendation
Fintel reports that on November 15, 2024, Wolfe Research initiated coverage of BioMarin Pharmaceutical (NasdaqGS:BMRN) with a ...
Fintel on MSN7h
Wolfe Research Initiates Coverage of Amgen (AMGN) with Peer Perform Recommendation
Fintel reports that on November 15, 2024, Wolfe Research initiated coverage of Amgen (NasdaqGS:AMGN) with a Peer Perform ...
U.S. Pharma is largely immune from 'MAHA' impact: Wolfe
Wolfe projects a positive outlook for Pharma & Large-Cap Biotech stocks despite potential policy changes as part of Make America Healthy Again movement. Read more here.